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Protein misfolding and aggregation have been linked to several
human diseases, including Alzheimer’s disease, Parkinson’s dis-
ease, and systemic amyloidosis, by mechanisms that are not yet
completely understood. The hallmark of most of these diseases is
the formation of highly ordered and -sheet-rich aggregates re-
ferred to as amyloid fibrils. Fibril formation by WT transthyretin
(TTR) or TTR variants has been linked to the etiology of systemic
amyloidosis and familial amyloid polyneuropathy, respectively.
Similarly, amyloid fibril formation by -synuclein (-syn) has been
linked to neurodegeneration in Parkinson’s disease, a movement
disorder characterized by selective degeneration of dopaminergic
neurons in the substantia nigra. Here we show that consecutive
cycles of compression–decompression under aggregating condi-
tions lead to reversible dissociation of TTR and -syn fibrils. The
high sensitivity of amyloid fibrils toward high hydrostatic pressure
(HHP) indicates the existence of packing defects in the fibril core.
In addition, through the use of HHP we are able to detect differ-
ences in stability between fibrils formed from WT TTR and the
familial amyloidotic polyneuropathy-associated variant V30M. The
fibrils formed by WT -syn were less susceptible to pressure
denaturation than the Parkinson’s disease-linked variants, A30P
and A53T. This finding implies that fibrils of -syn formed from the
variants would be more easily dissolved into small oligomers by
the cellular machinery. This result has physiological importance in
light of the current view that the pathogenic species are the small
aggregates rather the mature fibrils. Finally, the HHP-induced
formation of fibrils from TTR is relatively fast (60 min), a quality
that allows screening of antiamyloidogenic drugs.
In the last decade, effective treatments for several amyloidogenicand misfolding diseases have been sought (1, 2). In all of these
diseases, the protein associated undergoes a conformational change
and self-assembly to form highly ordered and -sheet-rich struc-
tures referred to as amyloid fibrils. The process of amyloid fibril
formation has been linked to tissues or organ dysfunction: heart and
peripheral nerves in the case of transthyretin (TTR), and neuro-
degeneration in the case of amyloid- peptide (Alzheimer’s dis-
ease) and -synuclein (-syn) (Parkinson’s disease) (3–6).
Parkinson’s disease is the second most common neurodegenera-
tive disorder in humans. It is associated with resting tremor,
postural rigidity, and progressive degeneration of dopaminergic
neurons in the substantia nigra pars compacta (6). Characteristic
pathological features of Parkinson’s disease include Lewy bodies,
which are juxtanuclear-ubiquitinated proteinaceous inclusions in
neuronal perikarya, and Lewy neurites, which are similar protein
aggregates found in neuronal processes (7). Biochemical analysis of
these inclusions revealed that-syn is the major constituent of these
neuronal inclusions, which points to its role in the ethiology of this
disease (8). Moreover, two missense mutations in the gene encod-
ing -syn are linked to dominantly inherited Parkinson’s disease,
thereby directly implicating -syn in the disease pathogenesis (9).
Amyloid fibril formation by WT TTR is responsible for senile
systemic amyloidosis, a disease that affects 25% of people 80
years old, and is characterized by heavy amyloid deposits in the
heart (3). More than 80 point mutants of TTR have been
described thus far, most of them involved in familial amyloidotic
polyneuropathy (FAP) (10). In general, FAP patients present
the first symptoms by the second or third decade with peripheral
neuropathy, cardiomyopathy, carpal tunnel syndrome, and vit-
reous opacities (3). The most widespread variant of TTR con-
tains the substitution V30M in -strand B, one of the eight
-strands present in TTR (5).
Here we describe the reversible dissociation of fibrils of-syn and
TTR assisted by high hydrostatic pressure (HHP). Pressure can
change the balance between misfolding and folding in different
ways, as recently demonstrated in rhodanese (11), the tailspike
protein of bacteriophage P22 (12), myoglobin (13), and the amy-
loidogenic protein TTR (14). Pressure is well known to disrupt
hydrophobic interactions and eliminate water-excluded cavities
(15). We show that the interactions underlying aggregation in vitro
can be reversed. Interestingly, the time and amount of pressure
needed to dissociate the fibrils do not differ significantly from (or
are even less than) those required to dissociate native oligomeric
proteins. Through the use of HHP we can detect differences in
stability between-syn fibrils composed by the variant A30P, A53T,
and WT protein. In addition, in view of the rapidity with which
fibrils of -syn and TTR undergo disassembly upon compression
and aggregation after decompression (TTR), we propose the use of
this methodology for drug screening.
Methods
TTR Fibril Formation and Dissociation. Recombinant TTR was
expressed and purified as described (16). Soluble WT or V30M
TTR (3.5 or 1 M of tetramers, respectively) was compressed at
3,000 bar (1 bar 100 kPa) during 30 min at 37°C at pH 5. After
this time, pressure was released, and the light scattering was
recorded with time as a measurement of aggregation, exciting
the samples at 320 nm and collecting the light at 90° through the
monochromator (315–325 nm). Light scattering and fluores-
cence were measured in an ISS spectrofluorimeter (Champaign,
IL). All TTR experiments were performed in 50 mM Mes
containing 100 mM KCl at pH 5.0.
Bis-(8-Anilinonaphthalene-1-sulfonate) (bis-ANS) Binding. The bis-
ANS binding was evaluated from its f luorescence on exciting the
sample at 360 nm and collecting the emission in the range
between 300 and 600 nm.
Abbreviations: TTR, transthyretin; -syn, -synuclein; Trp, tryptophan; TEM, transmission
electron microscopy; bis-ANS, bis-(8-anilinonaphthalene-1-sulfonate); FAP, familial amy-
loidotic polyneuropathy; HHP, high hydrostatic pressure.
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-Syn Fibril Formation and Dissociation. Recombinant -syn was
expressed and purified as described (17). Fibrils of -syn were
obtained by incubating 140 M of each sample (WT, A30P, and
A53T) at atmospheric pressure and 37°C, under gentle agitation.
The experiments were performed in 5 mM TrisHCl, 100 mM
NaCl, and 0.02% NaN3 at pH 7.5.
CD. CD spectra were recorded in a Jasco-715 spectropolarimeter
(Jasco, Tokyo). The baselines (buffer alone) were subtracted.
Congo Red and Thioflavin T Binding. Proteins were diluted to a final
concentration of 10 M in buffer (10 mM sodium phosphate2.7
mM KCl137 mM NaCl, pH 7.4) containing 2.5 M Congo red.
A477 and A540 were recorded and used to calculate the number of
moles of Congo red bound per liter, according to Glover et al. (18).
Thioflavin T binding was evaluated from the increase in spectral
area obtained on exciting the sample at 446 nm and collecting the
emission in the range 460–560 nm. The experiments were per-
formed in 50 mM glycine-NaOH at pH 8.5.
Transmission Electron Microscopy (TEM). The ultrastructure of-syn
fibrils was observed by TEM by using negative staining. The fibril
solution (0.5 mgml) was diluted 20-fold in water and then 10 l
of this solution was deposited on a Formvar-coated copper grid.
The grids were blotted to remove excess material, fixed with 10
l uranyl acetate (2% aqueous solution) for 1 min, and examined
in a JEOL 1200EX, operated at 80 kV.
Results
Pressure-Induced Dissociation of Preformed Fibrils of TTR. Previous in
vitro studies have shown that TTR amyloid fibril formation
requires tetramer dissociation to an alternatively folded mono-
mer, which then self-assembles into a ladder of soluble oligo-
meric intermediates, ultimately affording amyloid fibrils (19–
23). We have recently shown that after decompression, WT TTR
forms fibrils under mild conditions (pH 5–5.6, 37°C, [TTR]  1
M) (14). Using size-exclusion chromatography and bis-ANS
binding, we demonstrated that the main species recovered after
decompression under nonaggregating conditions (1°C) is a tet-
ramer with an altered conformation (T4*) and with weaker
association between the subunits. This species is highly amyloi-
dogenic, because under appropriate conditions (pH 5–5.6, 37°C)
it aggregates after pressure release, whereas lower pHs (pH
4–4.4) are usually required to induce the aggregation of the
native WT TTR tetramer.
To determine whether amyloid fibrils were susceptible to
HHP, fibrils of WT TTR and the FAP-associated variant V30M
were produced and subjected to high pressure (Fig. 1). Initial
fibrils were produced by subjecting soluble, tetrameric WT or
V30M TTR to high pressure for 30 min at pH 5.0 (37°C) (Fig.
1A), which has been shown to lead to the population of the
amyloidogenic form of TTR (14). The pressure was then re-
leased (Fig. 1B), and light scattering was used to monitor TTR
fibril formation, as described (14). V30M was observed to form
fibrils much faster and to a greater extent than the WT protein,
especially if we consider that a 3.5-fold higher concentration of
the WT protein was used. When the changes in the light
scattering leveled off (120 min for WT and 30 min for V30M),
pressure was applied again to evaluate its effects on the fibril
structure (Fig. 1C). In the case of WT fibrils, light scattering
dropped immediately to a very low value, suggesting complete
disassembly of the preformed WT fibrils and formation of a
small, soluble species, likely the monomeric form.
The compression of V30M fibrils also leads to a large decrease
in the light scattering; however, the final value was not as low as
the one obtained for WT (Fig. 1C), suggesting incomplete
partial disassembly of V30M fibrils. There are at least two
possibilities for interpreting the incomplete drop in the light
scattering: (i) V30M fibrils are heterogeneous in terms of
stability, and only the weaker fibrils are dissociated by HHP, thus
forming a mixture of intact fibrils and small species; or (ii) V30M
fibrils are homogeneous in terms of stability, and the whole
population of fibrils is dissociated into an oligomeric species that
scatters more light than the monomeric protein. In either case,
the expected final value would be larger than the one displayed
by monomers or tetramers of TTR.
The incomplete decrease in light scattering observed when
V30M fibrils are compressed suggests that, if all of the popula-
tion of V30M fibrils is equally sensitive to HHP (homogeneous
in terms of stability), there is a core or a ‘‘stone’’ in the fibril of
V30M that is pressure resistant. This observation may be phys-
iologically relevant and have important implications regarding
the stability of the fibrils against degradation and clearance
strategies that could be adopted by the organism.
After 70 min under 3,000 bar, decompression gave rise to new
fibrils in 30 min (Fig. 1D). Again, fibril formation by V30M
occurred much faster and to a greater extent than the WT
protein. Fig. 1 E and F shows that a third cycle of compression–
decompression also induced the complete dissociation of WT
fibrils but only a partial dissociation of V30M fibrils (Fig. 1E).
V30M fibrils produced under acid conditions (incubation of 1
M V30M at pH 5.0, 37°C, and at atmospheric pressure during
72 h) were also sensitive to HHP (data not shown).
These results indicate that TTR fibrils are sensitive to HHP,
as are other amorphous aggregates and inclusion bodies (11, 12,
24). Because HHP is very effective in disrupting ionic and
hydrophobic interactions but not in disrupting hydrogen bonds
(reviewed in refs. 15 and 25), we can infer that the first two types
of interactions have a major role in fibril maintenance. Because
pressure shifts the equilibrium toward the species that occupies
lower volume (15, 26), we can also conclude that there are
packing defects in the fibrils that render them susceptible to
dissociation by HHP. The results presented indicate that amyloid
fibrils formed by the WT protein would be easier to clear than
those formed by V30M, suggesting that the high propensity for
amyloid fibril formation and the decreased clearance of V30M
fibrils could contribute to the pathogenesis that leads to early-
age onset in FAP. Recently, Sousa et al. (27) described preamy-
loidogenic forms of V30M in the nerves of early FAP patients.
It is possible that the small oligomer we observed under pressure
represents this initial prefibrillar conformation, which was also
shown to be highly toxic to cell lines in culture (27).
To characterize the structure of the species released upon
dissociation of the WT fibrils by HHP, we took advantage of the
hydrophobic, f luorescent probe bis-ANS. The fluorescence in-
tensity of bis-ANS emission (Fig. 1G) and its maximum emission
wavelength (Fig. 1H) were used to monitor, respectively, the
presence of binding sites for this probe and their relative
hydrophobicity in the different species of TTR formed under
consecutive cycles of compression–decompression. ANS and
bis-ANS bind in the central channel (thyroxine-binding sites) of
TTR and exhibit a red-shifted emission spectrum upon binding
(28), consistent with the partial hydrophilic nature of this pocket
(Fig. 1H, bar 1). Upon compression (p), the fluorescence
intensity of bis-ANS increases 5-fold in relation to the soluble
protein, suggesting formation of a species with residual tertiary
contacts able to bind bis-ANS (Fig. 1G, bar 2, and ref. 14). In
addition, these new binding sites for bis-ANS are more hydro-
phobic and the maximum emission of the probe is located at 509
nm (Fig. 1H, bar 2). This result suggests that HHP is not
denaturing TTR completely but instead converting it into a
partially folded, monomeric conformation. In contrast, the fully
unfolded state of TTR induced by urea does not bind bis-ANS
(Fig. 1G, bar 6). When pressure is released and fibrillogenesis
takes place, there is a further increase of 15% in bis-ANS
emission and an added displacement in the maximum emission
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wavelength even more to the blue (Fig. 1H, bar 3), which is
compatible with the existence in TTR fibrils of hydrophobic
pockets accessible to the probe.
In the second cycle of compression, which results in complete
dissociation of WT TTR fibrils (Fig. 1C), there is a small decrease
in bis-ANS emission (Fig. 1G, bar 4), which returns to the same level
seen in the first compression (Fig. 1G, bar 2). In addition, a red shift
(from 504 to 509 nm) of the maximum emission (Fig. 1H, bar 4) to
the previous position is observed. This result suggests that pressure
induces recovery of a species with persistent tertiary contacts rather
than the completely unfolded monomer or the native tetramer.
Finally, when pressure is released, the fibrils are formed again and
the bis-ANS emission returns to the higher value (Fig. 1G, bar 5)
with a blue-shifted emission.
In addition to the changes in spectroscopic behavior of
bis-ANS upon fibril formation and dissociation, the maximum
emission wavelength of tryptophan (Trp) can furnish insight into
the environment experienced by this residue during its lifetime.
Fig. 1. (A–F) HHP induces dissociation of fibrils of WT and
V30M TTR. (A) WT TTR (3.5 M, F) or V30M (1 M, ) was
compressed at 3,000 bar (p) at pH 5 and 37°C for 30 min.
Then, pressure was released (p), and the light scattering (LS)
was recorded for 2 h (B). When the LS increase leveled off,
pressure () was applied again (C). (D–F) Another round of
decompression (), compression (), and decompression (),
respectively. LS was measured at 320 nm. (G and H) The species
rescued from the WT fibrils is partially folded and binds bis-
ANS. An experiment similar to that described in A–F was
performed in the presence of bis-ANS (2M WT TTR and 20M
bis-ANS) but measuring its fluorescence intensity (G, left ordi-
nate) and maximum emission wavelength (H, right ordinate).
Consecutive cycles of compression (p)decompression (p)
are shown, and the bars in G and H represent the following:
1, sample at atmospheric pressure (soluble, native tetramer);
2, sample after 60 min at 3,000 bar (partially folded state);
3, after returning to atmospheric pressure (fibril formation);
4 and 5, another cycle of compression (partially folded state)
and decompression (fibril formation), respectively; and 6, the
binding of bis-ANS to the urea-unfolded WT protein. (G) The
binding of bis-ANS under different conditions is normalized to
its binding to the native tetramer (AA0). (I) Diclofenac inhibits
WT TTR fibrillogenesis. Wt TTR (3.5 M) was compressed
at 3,000 bar in absence of diclofenac at 37°C. After 60 min, the
decompression was performed at 1°C to avoid aggregation.
The high-pressure cuvette was opened on ice, and 70 M
diclofenac was added to the sample. Then, the temperature
was raised to 37°C triggering aggregation, and the LS was
recorded (). A control curve (absence of diclofenac) is pre-
sented for comparison (F).







The Trp residues in the V30M and WT TTR tetramers face a
similar environment, based on similar emission wavelengths
(342–343 nm). Upon compression, a partially unfolded species
accumulates and the Trp residues are exposed to the aqueous
environment (maximum emission shifts to the red by5–6 nm).
When fibrillogenesis takes place after pressure release, the
maximum emission is strongly blue-shifted (340–341 nm), which
is compatible with Trp burial in the fibril core.
Recently, several nonsteroidal antiinflammatory drugs have
been described to inhibit TTR fibrillogenesis by stabilizing the
native tetrameric structure and preventing the formation of the
monomeric amyloidogenic intermediate (29–31). We sought to
investigate whether addition of diclofenac, a known inhibitor of
TTR acid-induced amyloid fibril formation, could also be effective
in preventing fibrillogenesis after an amyloidogenic conformation
had been generated (Fig. 1I). Therefore, the drug was added after
the first cycle of compression at 1°C (i.e., to the altered tetramer,
T4*) and then the temperature was raised up to 37°C to trigger
amyloid fibril formation. Fig. 1I shows that diclofenac completely
inhibits aggregation of WT TTR even when it has been primed to
the amyloidogenic state (previous treatment with pressure). In
conclusion, the species present after decompression (T4*) not only
binds bis-ANS more strongly than the native protein, but it also
binds the ligand diclofenac, which blocks reaggregation. We pro-
pose that this cyclic high-pressure methodology would be useful for
drug screening because after pressure release fibrillogenesis occurs
very rapidly, requiring few minutes for completion what allows the
screening of a large amount of compounds in a short period and in
more amenable pH range (pH 5 instead of 4).
To better characterize the difference in stability between WT
and V30M fibrils, high-pressure titration curves were performed
(Fig. 2). Again, the WT fibrils were completely dismantled by
HHP, whereas V30M fibrils were only partially dissociated (Fig.
2). It is worth emphasizing that the p1/2 value (half-maximal
dissociation) observed for WT TTR fibrils was 1,750 bar, a value
that is close to those reported for the dissociation of dimers (for
instance, Arc Repressor), trimers (allophycocyanin), tetramers
(lactate dehydrogenase), and other oligomers (virus particles in
general) (15, 26). In fact, the p1/2 value found for the dissociation-
denaturation of WT TTR tetramers at 37°C was equal to 2,700
bar (14), even larger than that reported here for the WT fibrils.
This result suggests that the contacts that hold the protein tightly
packed into the fibrils are weaker than those present among the
monomers in the tetramer. Because of the greater sensitivity of
TTR fibrils to HHP in comparison to the tetramer, we infer that
van der Waals minima for the protein–protein contacts are less
satisfied inside the fibrils than in the tetramer; this generates void
volumes inside the fibrils. Curiously, the p1/2 values for the
dissociation-denaturation of L55P and V30M tetramers were
1,500 and 1,850 bar, respectively (32); these values are much
closer to that observed for the dissociation of WT TTR fibrils.
This result suggests that the contacts that hold the WT TTR
fibrils together are weak as those already present in the tetramers
of the amyloidogenic variants of TTR, which may be related to
the tendency for variants to undergo fibrillogenesis much faster
and also to exhibit lower thermodynamic stability.
Pressure-Induced Dissociation of Preformed Fibrils of -syn. Al-
though 20 different proteins have been found to be involved in
amyloidogenic diseases, most of them are unrelated structurally at
the level of primary sequence. Despite these differences, all of the
amyloid fibrils from different pathologies display common prop-
erties. Typically, they consist of two to six unbranched profilaments
(2–5 nm wide) associated laterally or twisted together to form the
fibrils that are 4–13 nm wide (33). The cross -sheet topology has
been observed in all fibrils thus far analyzed (34). To investigate
how another type of amyloid fibril responds to HHP, we examined
fibrils formed from -syn, the amyloid protein involved in Parkin-
son’s disease. Solutions of -syn were incubated for 6 days (WT and
A30P) or 24 h (A53T) at 37°C and pH 7.5 under gentle agitation
to induce fibrillogenesis. At this time, in which the increase in A at
330 nm leveled off, the solutions of the WT and variant fibrils were
subjected to increasing pressures (Fig. 3A), and the light scattering
was measured at each pressure after 10 min equilibration. Scatter-
ing decreased as pressure was increased, indicating that -syn fibrils
are also sensitive to HHP (Fig. 3A). Interestingly, fibrils formed
Fig. 2. Pressure titration of WT (F) and V30M () fibrils. The soluble proteins
were subjected to a cycle of compression–decompression under aggregating
conditions (pH 5, 37°C) to induce fibril formation. Then, pressure was applied
in steps and the light scattering was recorded as in Fig. 1. The initial light
scattering value of the fibrils was taken as 100% aggregation.
Fig. 3. (A) Pressure titration of -syn fibrils from WT and variant proteins.
Fibrils were produced at atmospheric pressure (see text) and then subjected to
increasing pressure at 37°C while recording the light scattering (LS) as in Fig.
1. Proteins were: WT (), A53T (F), and A30P (Œ). The isolated symbols on the
left represent the LS values obtained after decompression. (B) Kinetics of the
pressure-induced dissociation of WT and variant fibrils of -syn. The fibrils
solutions were compressed at 1,700 bar at 37°C. The extent of fibril dissocia-
tion was recorded at intervals as a decrease in LS in comparison to the initial
value (LS0). Symbols are same as in A.
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from the PD-linked variants of -syn were more sensitive to high
pressure than the WT fibrils. The p1/2 values were800, 1,350, and
1,850 bar for the dissociation of A53T, A30P, and WT fibrils,
respectively. After decompression of each protein, the light-
scattering values remained low, showing no sign of aggregation
(isolated symbols on the left in Fig. 3A). Taken together, these
results suggest that HHP treatment converts the fibrils of -syn into
a soluble form that does not undergo fibrillogenesis immediately
after pressure removal. The kinetics of fibril dissociation were
examined at 1,700 bar (Fig. 3B). Again, the A53T fibrils dissociated
more rapidly (20 min) even at this moderate pressure, whereas the
fibrils of A30P and WT protein dissociated much more slowly.
CD was used to obtain insight into the secondary structural
changes induced by HHP treatment on the -syn fibril structure.
Fig. 4A shows the CD spectra of the WT soluble protein before
fibrillogenesis and the spectra of the fibrils and of the species
rescued from the fibrils after HHP. Before compression, soluble
-syn exhibited a CD signal (an ellipticity minimum at 198 nm) that
is consistent with a predominantly random coil, whereas aggregated
-syn exhibited a signal (minimum at 220 nm) that is characteristic
of a -sheet-rich structure. The -syn recovered from pressure
denaturation of the fibrils revealed CD spectrum that is identical to
the soluble protein, indicating that high pressure results in both
dissociation and unfolding of -syn fibrils (Fig. 4A).
To confirm the dissociation of -syn fibrils by HHP, we used
the amyloid specific dyes Congo red and thioflavin T to monitor
the formation and dissociation of the -syn fibrils as a function
of pressure (Fig. 4B). Both WT and A53T fibrils bound the
Congo red and thioflavin T consistent with the formation of a
fibril-like structure. In contrast, the binding of both dyes to the
species present after decompression was reduced to the same
level as that observed for the soluble forms of the proteins.
To evaluate whether the species recovered from the fibrils by
HHP treatment retains its ability to undergo self-assembly into
amyloid fibrils, the samples were incubated after decompression
under gentle agitation at 37°C and the aggregation was monitored
by turbidity at 330 nm (Fig. 4C). The A53T variant undergoes
aggregation faster than the WT protein, consistent with previous
reports (17, 35). Interestingly, in both cases the aggregation time
course observed for the soluble species rescued by pressure treat-
ment was very similar to that seen for the soluble, virgin proteins.
To investigate the presence or absence of fibrils in these samples,
TEM images were collected (Fig. 4C Inset). Fig. 4C Upper shows
that after decompression there are no detectable fibrils in the
sample (although the fibrils were there before compression as seen
by TEM, not shown). After incubating this sample under suitable
conditions (gentle agitation at 37°C for 120 h), fibrils reappear
showing a native-like morphology (Fig. 4C Lower). This result
indicates that HHP treatment dissociates preformed fibrils of both
WT and variant-syn into soluble, native-like, and fibril-competent
species, suggesting that -syn fibrillogenesis is a reversible process
under appropriate conditions.
Fig. 4. Characterization of the species rescued from -syn fibrils dissociated
by HHP. (A) CD spectra of the soluble WT -syn (continuous line); fibrils
(long-dashed line); and the species rescued from HHP treatment (dashed line).
(B) Binding of Congo red (filled bars) and thioflavin T (empty bars) to WT (Left)
and A53T -syn (Right) in the form of soluble protein, fibrils, and species
rescued from the fibrils (after pressure). (C) Time course of fibril formation (see
text) is expressed as the OD at 330 nm for the virgin, soluble protein (open
symbols) and the soluble species rescued from the fibrils by HHP (filled
symbols). Squares, WT protein; circles, A53T variant. (Inset) TEM images of the
WT species rescued from the fibrils by HHP treatment (Upper) and of the fibrils
reformed from this sample (Lower) after incubation under appropriate con-
ditions (37°C, gentle agitation for 120 h). (Bar  150 nm.)
Fig. 5. Schematic representation of the effects of HHP on the fibrils of WT
TTR and -syn. The core of the amyloid fibrils is not perfectly packed, creating
cavities that render the fibrils susceptible to HHP. Upon compression (p),
water infiltrates and dissociation takes place, forming either a partially folded
species, as in the case of WT TTR, or a native, unfolded monomer, as in the case
of -syn. In the case of TTR fibrils, Trp and bis-ANS present a blue-shifted
emission, suggesting that both fluorophores lie in nonpolar environments.
Upon fibril dissociation, the partially folded species of TTR is formed, the Trps
are exposed to solvent (red-shifted emission), and the bis-ANS binding pocket
is more hydrophilic than in the fibrils. Upon pressure release (p), the partially
folded species of TTR reforms fibrils in 1 h, whereas the native, unfolded
-syn has lost none of its amyloidogenic properties and can aggregate as fast
as the virgin, soluble protein.








Our data show the high sensitivity of the amyloid fibers formed
from - syn and TTR to a physical agent such as HHP. The amyloid
fibrils undergo dissociation in a pressure range comparable to that
observed for small oligomers (26). Although the proteins compos-
ing the fibrils are well structured, they appear to have water-
excluded cavities that make them highly susceptible to pressure
denaturation (Fig. 5). The individual structure and stability of
proteins and multimolecular assemblies reside in their packing
characteristics (15, 36). Recent theoretical approaches provide a
link between the hydration of hydrophobic surfaces and excluded
volume (37, 38). Hydration can account for pressure effects such as
those reported here: pressure causes infiltration of water molecules
into the hydrophobic core of the protein. It has been previously
shown that pressure denaturation does not occur when water is
withdrawn (15, 39, 40). Pressure dissociates amyloid fibers because
they possess water-excluded cavities that bind hydrophobic com-
pounds such as bis-ANS. Fig. 5 depicts the findings described here.
The main difference in behavior between TTR and-syn is that the
structured intermediate of TTR leads to fast reaggregation after
decompression whereas the unstructured, soluble -syn has a slow
kinetics of aggregation equal to the native protein. These findings
not only point toward possible mechanisms of pathogenesis but also
imply that different strategies should be sought to attack the two
diseases: for -syn, compounds that destabilize any structured
oligomer will be the best choice, whereas for TTR, only drugs that
prevent the fibril formation may be effective. Above all, the
water-excluded cavities that prevail in both types of fibrils (Fig. 5)
should be considered in any search for the development of new
drugs.
Our data also show that the pressure dissociation of fibrils
occurs in the same time frame and in the same pressure range
of that required for dissociation of native oligomeric proteins.
This finding implies that the same properties allowing subunit
dissociation of oligomeric proteins, such as packing defects and
hydrophobic pockets, are likely present in the fibrils. Recently,
Torrent et al. (41) described that high pressure (2,000 bar)
dissociates the high temperature-induced aggregates of recom-
binant prion protein. However much higher pressures (12,000
bar) at high temperature conditions (100°C) were recently
demonstrated to be able to inactivate prion infectivity in pro-
cessed meat (42). On the other hand, the yeast prion protein
Ure2 undergoes only limited perturbation at a pressure of 6,000
bar (43).
Our data point to the use of HHP as a valuable tool for
populating important intermediate states competent for fibril-
logenesis, as demonstrated for TTR, as well as for the original
native-unfolded species of -syn. In the case of -syn fibrils, the
aggressive variants are more susceptible to pressure than WT.
This result is significant in the light of recent evidence that
oligomeric aggregates, rather than the fibrils themselves, are
more important for the pathogenesis (44–46). In this respect, the
weaker fibrils of the variants of -syn would generate small
oligomers when the cellular machinery tries to get rid of them.
Whereas the mutant -syn fibrils present easier dissociation than
the WT form, a different pattern is found for the V30M TTR in
comparison to WT TTR. In the case of TTR, the formation of
pressure-resistant core derived from the V30M fibrils would also
be more toxic and pathogenic than the soluble species derived
from the WT fibrils.
In conclusion, our data show that the amyloid fibrils, although
similar in architecture, present differences in stability probably
related to the existence of packing defects in their core. These
packing defects are generated by the imperfect contact between the
side chains inside fibril structure, which suggests that the amino acid
sequence may play an important role in fibril stability.
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